[1]
2024. Recurrent statin-induced rhabdomyolysis: Commonly overlooked drug. Indian Journal of Case Reports. 10, 2 (Mar. 2024), 54–55. DOI:https://doi.org/10.32677/ijcr.v10i2.4299.